Clinical Trial Update: A Study to Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating KRIYA-825 (VV-14295) for geographic atrophy due to age-related macular degeneration is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Geographic Atrophy Secondary to Age-related Macular Degeneration

Drugs mentioned

• KRIYA-825 (KRIYA-825)

Snippet

Sponsor: Kriya Therapeutics, Inc. | Conditions: Geographic Atrophy Secondary to Age-related Macular Degeneration | Phase 1, Phase 2 | Status: RECRUITING